Molecular analysis of the distal enhancer of the mouse alpha-fetoprotein gene.

Molecular and Cellular Biology
J H MillonigS M Tilghman

Abstract

The mouse alpha-fetoprotein (AFP) gene is transcribed at high levels in the visceral endoderm of the yolk sac and fetal liver and at much lower rates in the endoderm of the fetal gut. Expression of the gene in vivo requires the presence of at least one of three enhancers which lie in its 5' flanking region. In this report, we establish that the most distal AFP enhancer directed consistent expression of a linked AFP minigene in all three endodermal tissues in transgenic mice. The enhancer is composed of three domains, each of which is essential for full enhancer function by transient transfection assays. DNase I footprinting identified three regions of the enhancer which are protected by human hepatoma nuclear extracts, one of which corresponded to a consensus site for HNF-3 binding. Site-directed mutations in this site caused a 10-fold reduction in enhancer function by transient transfection. In transgenic mice, however, the mutation resulted in sporadic expression of the transgene, dependent on the site of integration. A similar acquisition of position-dependent sporadic expression of the transgene was observed with a mutation in a second protein binding site, despite the fact that this mutation had very little effect on enhan...Continue Reading

References

Apr 1, 1990·The Journal of Cell Biology·A L TynerS M Tilghman
Jan 1, 1990·DNA Sequence : the Journal of DNA Sequencing and Mapping·G Buzard, J Locker
Jan 25, 1988·Nucleic Acids Research·T F VogtS M Tilghman
Aug 1, 1988·Genes & Development·R Godbout, S M Tilghman
Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·G CourtoisG R Crabtree
Oct 1, 1989·Molecular and Cellular Biology·M H FeuermanS M Tilghman
Jun 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·R H CostaJ E Darnell
Jul 1, 1988·Genes & Development·W H LandschulzS L McKnight
Jun 14, 1967·Journal of Molecular Biology·B Hirt
Jun 1, 1972·Proceedings of the National Academy of Sciences of the United States of America·H Aviv, P Leder
Sep 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·P S Thomas
Jan 1, 1982·Developmental Biology·G K AndrewsT Tamaoki
Sep 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·S M Tilghman, A Belayew
Jun 1, 1980·European Journal of Biochemistry·C Auffray, F Rougeon

❮ Previous
Next ❯

Citations

Jun 1, 1996·Mechanisms of Development·E Kaufmann, W Knöchel
Sep 7, 2011·Cellular Signalling·Kewei Wang, Ai-Xuan Holterman
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·D K JinM H Feuerman
May 20, 1998·Proceedings of the National Academy of Sciences of the United States of America·H SassiT Grange
May 18, 2004·Biochemical and Biophysical Research Communications·Hidekazu NakabayashiShinzo Nishi
Sep 25, 1996·Molecular & General Genetics : MGG·G DonofrioC B Whitelaw
Jan 21, 2010·Physiological Reviews·John Le Lay, Klaus H Kaestner
Jun 8, 2000·The Journal of Biological Chemistry·W R VorachekJ Locker
Sep 17, 1998·The Journal of Biological Chemistry·C GregoriA L Pichard
Aug 9, 2002·Molecular and Cellular Biology·Yasuo KajiyamaJoseph Locker
Sep 11, 2002·Toxicology in Vitro : an International Journal Published in Association with BIBRA·M PaparellaS Bremer

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.